ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2495

Tele-Monitoring of Disease Activity in Rheumatoid Arthritis and Psoriatic Arthritis

Alexander Langer1 and Hans-Eckhard Langer2, 1Department of Computer Science, RWTH Aachen University, Aachen, Germany, 2RHIO (Rheumatology, Immunology, and Osteology), Duesseldorf, Germany

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Disease Activity, online patient engagement, Psoriatic arthritis, rheumatoid arthritis (RA) and self-management

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 10, 2015

Title: Quality Measures and Quality of Care Poster Session

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:

There is evidence that tight control of rheumatoid arthritis improves outcome. In daily practice this aim is constricted by logistic limitations such as a small number of rheumatologists or long distances to specialized centers. By tele-monitoring the disease activity between regular routine controls and individually tailoring control intervals, we might be able to optimize disease management. In this study, we examine the acceptance and usage of an online tele-monitoring tool.

Methods:

The tele-monitoring tool was developed as a patient empowerment platform for an internet community for patients of chronic arthritis. The program includes electronic versions of the DAS28 and the HAQ as well as a form to regularly (e.g., daily) document disease activity (scale 0-10; 0=lowest, 10=highest), pain (0-10) and fatigue (0-10), swollen and tender joints, drugs taken and any noteworthy events such as flares or special occasions in the patient’s life. The monitoring data can be made available to the rheumatologist who can then react appropriately.

Between 2011 and 2015, 2732 users of the internet community signed up for the program, out of which 1233 patients voluntarily provided their age, gender and diagnosis. 616 subjects with RA (n=503) or PsA (n=114) were chosen for further analysis.

Results:

The mean age at registration was 45.0 ± 12.2 years (range 13-82); 467 (76%) subjects are female. 279 patients (45%) used the program less than two weeks. The remaining 337 patients (55%) used the program for 323.8 ± 352.5 days on average, with an average frequency of once every 32.4 ± 57.4 days.

415 patients regularly entered disease activity (totaling n=17691 entries; average of 3.07 ± 2.50), pain (n=19325 entries; average 3.27 ± 2.50), or fatigue (n=18198; average 3.42 ± 2.83). The DAS28 test was performed by 275 patients; the average score after registration was 4.68 ± 1.44 (range 0.42 – 8.91; median 4.71). The average HAQ score (333 patients) was 1.11 ± 0.67 (range 0 – 2.86; median 1.13).

Conclusion:

The tele-monitoring tool is well-received. The majority of patients that signed up continued to use it regularly. Patients seem to prefer simple scores that can be entered quickly over more involved tests such as the DAS28 or the HAQ.

It remains open why some patients discontinued the usage of the tele-monitoring tool. With additional training and support by health care providers such as the primary physician it might be possible to improve the persistency in tele-monitoring as well as the acceptance of lengthier tests such as the DAS28 or HAQ. Here we see chances and challenges for a more broader application of tele-monitoring tools.

The average user of the tele-monitoring tool is rather young, has a high disease activity and reduced functional capacity. This might be an indication that particularly patients with a severe arthritis seek help in additional tools for coping with their disease.


Disclosure: A. Langer, None; H. E. Langer, None.

To cite this abstract in AMA style:

Langer A, Langer HE. Tele-Monitoring of Disease Activity in Rheumatoid Arthritis and Psoriatic Arthritis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/tele-monitoring-of-disease-activity-in-rheumatoid-arthritis-and-psoriatic-arthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/tele-monitoring-of-disease-activity-in-rheumatoid-arthritis-and-psoriatic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology